Major Setback For Alzheimer Patients: Crucial Drug Fails Clinical Examination And Trial

The drug formulated which was claimed to be promising in treating Alzheimer's is now a mere killer and has failed the trial test. A lot of hopes were pinned on the success of this drug but it failed to prove the worth The drug failed to slow down the disease as compared to placebo.People in an early stage of Alzheimer's given placebo for months showed more improvement than Eli Lilly's solanezumab.

The third trial of this drug was conducted and it did not give the expected results.A lot of people are disheartened as they were expecting it to be the potential treatment of the disease. The drug and it results are under evaluation, news.com.au states.

During past few years, an enormous number of Alzheimer's treatment drugs have failed to produce the results.Experts are of the opinion that it is a major setback which is very disappointing.Many people were looking forward to the drug to get them rid of Alzheimer's but the trial failed to produce any potential improvement.

A combination of various things are required to control this disease,as any drug ever formulated has failed to give any improved result. Multiple approaches are required to be taken by Alzheimer's diagnosed individuals.A change of lifestyle is required to tackle this problem.It has been found out that ultrasound technology is very well successful in reversing the effects of Alzheimer's.

Stress and anxiety affect brain's ability and it makes the individual lose memorizing power.One should stay away from stress. Exercise is yet another way to cure this disease as it improves the development of new neurons.

Prevention is better than cure.Precautions should be taken to avoid developing the disease.These other means along with drugs and placebo should be given prime importance because nothing has proved itself to be a potential treatment for Alzheimer's.